Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Request for information - E60PH-28MPIV - Pandemic Influenza Vaccine Readiness and Supply Strategy

Active
WS5703210526Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Canada is seeking input from potential suppliers to inform its medium- and long-term strategy for securing sufficient pandemic influenza vaccine readiness and supply, with the goal of ensuring capacity to produce up to 110 million doses of a monovalent pandemic influenza vaccine. This request for information is part of a broader effort to establish a robust and reliable supply chain capable of responding swiftly to future influenza pandemic threats. Suppliers are invited to provide details on their capabilities, production scalability, and readiness to meet Canadian public health needs, helping the government assess the market and shape future contracting opportunities. The solicitation, identified by number WS5703210526 and issued by the Department of Public Works and Government Services on behalf of the Government of Canada, is open for responses until August 7, 2026. The primary point of contact for inquiries is Yessica Karnali Wijaya Putri, Contracting Authority within the Specialized Procurement and Services Division. While this is not a formal procurement, the feedback collected will directly influence the design and requirements of future binding contracts for pandemic influenza vaccine production and supply across the nation. The place of performance is Canada, and the initiative underscores the federal government’s proactive approach to national health security through strategic industry engagement.

General Info

Canada seeks supplier capabilities to ensure 110 million pandemic flu vaccine doses by 2026.

Agency

Government of Canada → Department of Public Works and Government ServicesView Agency

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

Canada, CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency Profile
Office AddressN/A
Contacts
Wijaya Putri Yessica Karnali (SPAC/PSPC) (elle-la / she-herContracting Authority

Full Description

Show more
Canada has a requirement for Pandemic Influenza Vaccine (PIV) readiness and supply to secure sufficient production capacity for up to 110 million doses of a monovalent PIV. To support the development of these requirements, Canada is seeking input from suppliers with a potential interest in bidding on future PIV Readiness and Supply contract(s), to address Canada’s medium- and/or long-term PIV readiness and supply needs.

Similar Contracts

NAICS: 325414
New
Federal
Diagnostic Reagents and Test Kit SupplyThe contract requires the supply of pre-qualified diagnostic reagents, media, and test kits specifically for use in culture, immunoassay, and molecular testing within NAHLN laboratories. These materials must meet stringent quality and performance standards to support diagnostic accuracy and consistency across federal laboratories. The procurement is classified as a subcontract with a NAICS code of 325414, indicating the focus on pharmaceutical and biological product manufacturing. The opportunity was posted on June 17, 2026, and responses must be submitted by June 16, 2027, at 10:00 PM Eastern Time, providing a one-year window for interested parties to prepare and submit proposals. The place of performance is designated as Ames, Iowa, with a zip code of 50010, suggesting that while the contract is administered by the Department of Agriculture under the Mrpbs Minneapolis Mn entity, deliverables will be routed to this primary operational location. There is no specified set-aside type, meaning the contract is open to all eligible vendors regardless of business size or ownership characteristics. The absence of a designated point of contact implies that all inquiries should follow standard SAM.gov submission protocols. Participation requires adherence to federal procurement guidelines, and vendors must ensure that their products are fully compatible with the diagnostic workflows of NAHLN labs, maintaining traceability, stability, and compliance with biosafety and regulatory requirements.
Mrpbs Minneapolis Mn

POSTED

6 days ago

DEADLINE

in 12 months
View Details